[Form 4] Cencora, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Robert P. Mauch, President & CEO and Director of Cencora, Inc. (COR), reported option exercises and open-market sales on 08/18/2025. He exercised 3,225 non-qualified stock options with an exercise price of $86.09 under a grant that vests in four prior annual installments, and those options produced 3,225 shares recorded as acquired. The same day he sold 4,968 shares at $293.53 per share pursuant to a Rule 10b5-1 trading plan adopted 11/15/2024. After these transactions he beneficially owned 40,608 shares and held 22,577 derivative securities (options) reported as direct ownership.
Positive
- Transactions executed under a Rule 10b5-1 trading plan, which provides an affirmative defense and reduces regulatory ambiguity
- Exercise price of $86.09 vs sale price $293.53 indicates a favorable spread for the reporting person, demonstrating value creation from prior grants
- Filing discloses post-transaction holdings (40,608 shares and 22,577 options), improving transparency for investors
Negative
- Insider sale of 4,968 shares could be viewed negatively by some investors, though it was performed under a pre-established plan
- Form does not state the economic proceeds or the percentage of total outstanding shares represented, limiting assessment of market impact
Insights
TL;DR: CEO exercised vested options then sold a portion of shares via a pre-established 10b5-1 plan; transactions appear routine and pre-planned.
The filing shows a standard exercise of vested non-qualified options and contemporaneous sales executed under a Rule 10b5-1 plan adopted on 11/15/2024, which provides the reporter an affirmative defense against insider trading claims. The exercise price ($86.09) is substantially below the sale price ($293.53), indicating a cash-positive outcome for the reporting person but the Form 4 does not state the proceeds or purpose of the sale. Holdings after the transactions are disclosed, improving transparency on insider position.
TL;DR: Compensation-related option exercise followed by sales under a 10b5-1 plan; typical liquidity event for vested equity.
The derivative detail confirms the exercised options were part of a multi-year vesting schedule with prior vesting dates listed. The report clarifies that the sale occurred under an established trading plan, reducing legal/regulatory risk. There is no indication in this filing of unplanned or opportunistic insider activity; however, materiality to shareholders depends on the size of holdings relative to outstanding shares, which is not provided here.